Thomas X - Search Results

1

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Foà R, Bassan R, Arslan Ö, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Brüggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z, Topp MS. Kantarjian H, et al. Among authors: thomas x. N Engl J Med. 2017 Mar 2;376(9):836-847. doi: 10.1056/NEJMoa1609783. N Engl J Med. 2017. PMID: 28249141 Free PMC article. Clinical Trial.

2

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

3

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

4

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.

Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. Thomas X, et al. Leukemia. 1995 Feb;9(2):249-53. Leukemia. 1995. PMID: 7532767

5

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

Archimbaud E, Thomas X, Leblond V, Michallet M, Fenaux P, Cordonnier C, Dreyfus F, Troussard X, Jaubert J, Travade P, et al. Archimbaud E, et al. Among authors: thomas x. J Clin Oncol. 1995 Jan;13(1):11-8. doi: 10.1200/JCO.1995.13.1.11. J Clin Oncol. 1995. PMID: 7799010

6

Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.

Thomas X, Danaïla C, Bach QK, Dufour P, Christian B, Corront B, Bosly A, Bastion Y, Gratecos N, Leblay R, et al. Thomas X, et al. Ann Hematol. 1995 Feb;70(2):65-9. doi: 10.1007/BF01834381. Ann Hematol. 1995. PMID: 7880925 Clinical Trial.

7

Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia.

Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D. Archimbaud E, et al. Among authors: thomas x. J Clin Oncol. 1994 Feb;12(2):262-7. doi: 10.1200/JCO.1994.12.2.262. J Clin Oncol. 1994. PMID: 8113835 Clinical Trial.

8

Timed sequential chemotherapy for advanced acute myeloid leukemia.

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Dreyfus F, Cony-Makhoul P, Tilly H, Troussard X, Auzanneau G, Thomas X, Ffrench M, Marie JP. Archimbaud E, et al. Among authors: thomas x. Hematol Cell Ther. 1996 Apr;38(2):161-7. doi: 10.1007/s00282-996-0161-2. Hematol Cell Ther. 1996. PMID: 8931997 Clinical Trial.

9

Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy.

Thomas X, Anglaret B, Thiebaut A, Belhabri A, Treille-Ritouet D, Fiere D, Archimbaud E. Thomas X, et al. Ann Hematol. 1997 Nov-Dec;75(5-6):195-200. doi: 10.1007/s002770050342. Ann Hematol. 1997. PMID: 9433375

10

Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.

Thomas X, Thiebaut A, Olteanu N, Danaïla C, Charrin C, Archimbaud E, Fiere D. Thomas X, et al. Hematol Cell Ther. 1998 Jun;40(3):119-28. Hematol Cell Ther. 1998. PMID: 9698220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page